← All indications
ST Elevation Myocardial Infarction
A clinical syndrome defined by MYOCARDIAL ISCHEMIA symptoms; persistent elevation in the ST segments of the ELECTROCARDIOGRAM; and release of BIOMARKERS of myocardial NECROSIS (e.g., elevated TROPONIN levels). ST segment elevation in the ECG is often used in determining the treatment protocol (see also NON-ST ELEVATION MYOCARDIAL INFARCTION).
Drugs by status
Approved for this indication (1)
Phase 4 trials (44)
- ezetimibe
- nitroglycerin
- heparin
- bempedoic acid
- dabigatran
- cangrelor
- ketotifen
- abciximab
- tenecteplase
- rosuvastatin
- ketorolac
- levosimendan
- metoclopramide
- nebivolol
- oseltamivir
- evolocumab
- atorvastatin
- colchicine
- ticagrelor
- ropivacaine
- acetaminophen
- prasugrel
- epinephrine
- acetylsalicylic acid
- alteplase
- clonidine
- alprostadil
- carvedilol
- fentanyl
- rivaroxaban
- +14 more
Phase 3 trials (19)
Phase 2 trials (26)
- methylprednisolone
- acp-501
- anfibatide
- alprazolam
- caplacizumab
- bq-123
- elamipretide
- empagliflozin
- fexofenadine
- ic14
- eptifibatide
- lc28-0126
- nitric oxide
- np202
- olokizumab
- alirocumab
- roxadustat
- sodium sulfide
- stem cells
- thymosin beta-4
- allogeneic adipose derived mesenchymal stem cell
- perflutren protein-type a microspheres
- prostaglandin
- Octafluoropropane
- ath3g10
- rtp-026
Organizations
Organization Involved with Phase 4 Indications (78)
- AstraZeneca
- Novo Nordisk
- Pfizer
- Chiesi
- Green Valley Group of China
- Guangzhou Recomgen Biotech Co., Ltd.
- CLI Foundation
- Danish Heart Foundation
- University of Roma La Sapienza
- Region Skane
- Huazhong University of Science and Technology
- Aarhus University
- Central South University
- Azienda Sanitaria Ospedaliera
- Istituto Clinico Sant'Ambrogio
- Kyung Hee University
- Lund University
- Medical Center of South Arkansas
- Seoul National University
- Universidad Complutense de Madrid
- University of Florence
- University of Florida
- University of Liverpool
- University of Milan
- University of Patras
- University of Southern Denmark
- University of Athens
- University of Bern
- Yonsei University
- Capital Medical University
- +48 more
Organization Involved with Phase 3 Indications (60)
- Roche
- Eli Lilly
- Sanofi
- Boston Scientific Corporation
- GlaxoSmithKline
- Suzhou Landing Pharmaceuticals
- Suzhou RxD Biopharmaceutical Co., Ltd
- Dexa Medica Group
- ZonMw: The Netherlands Organisation for Health Research and Development
- Medical Research Council
- Vastra Gotaland Region
- Canadian Heart Research Centre
- University of London
- Clinical Centre of Serbia
- Dong-A University
- Duke University
- Hellenic Cardiovascular Research Society
- Hospital do Coracao
- Iuliu Hatieganu University of Medicine and Pharmacy
- McMaster University
- Stanford University
- Cayetano Heredia University
- University of Groningen
- University of Leeds
- University of Ottawa
- University of Sussex
- University of Sydney
- University of Aberdeen
- University of Alberta
- University of Birmingham
- +30 more
Organization Involved with Phase 2 Indications (59)
- Schering-Plough
- Genentech
- Novartis
- Angion Biomedica Corp
- Armaron Bio Pty Ltd
- CardioCell LLC
- Diagram B.V.
- LG
- Mallinckrodt
- Polyphor Ltd.
- R-Pharm
- RegeneRx Biopharmaceuticals, Inc.
- Sponsor GmbH
- Stealth BioTherapeutics Inc.
- Fondazione Poliambulanza Istituto Ospedaliero
- Swiss National Science Foundation
- National Heart, Lung, and Blood Institute (NHLBI)
- National Institute on Aging (NIA)
- Samsung Medical Center
- Azienda Ospedaliera San Gerardo di Monza
- Harvard University
- Emory University
- Federal University of Rio Grande do Sul
- First People's Hospital of Foshan
- Gottfried Wilhelm Leibniz Universität Hannover
- Katholieke Universiteit Leuven
- Justus Liebig University Giessen
- University of Leicester
- University of Zurich
- Columbia University
- +29 more
Organization Involved with Phase 1 Indications (1)
Organization Involved with Other Experimental Indications (35)
- AORTICA Group
- Hamilton Health Sciences Corporation
- Henan University of Traditional Chinese Medicine
- RWTH Aachen University
- Russian Academy of Medical Sciences
- Spanish Society of Cardiology
- University of Kentucky
- University of Lausanne
- Zhengzhou University
- Institute of Cardiology, Tomsk, Russia
- Xinxiang Medical University
- Henan Medical University
- University of Barcelona
- Nanyang Central Hospital
- Anyang Regional Hospital
- Puyang Oil Field General Hospital
- Shenma Medical Group General Hospital
- Xinyang Central Hospital
- University of Salamanca
- Shantou University
- Lushan People’s Hospital
- Jincheng People’s Hospital
- Zhumadian Central Hospital
- Zhoukou Central Hospital
- Zhengzhou Cardiovascular Hospital
- Yellow River Sanmenxia hospital
- Yanshi People’s Hospital
- The Second People's Hospital of Pingdingshan
- The second people's Hospital of Jiyuan
- The First People's Hospital of Shangqiu
- +5 more